跳至主要内容
临床试验/NCT07419997
NCT07419997招募中不适用

A Multicenter, Retrospective, Observational Cohort Study on Intravenous Thrombolysis Beyond the Time Window for Acute Ischemic Stroke

Xuanwu Hospital, Beijing1 个研究点 分布在 1 个国家目标入组 2,600 人开始时间: 2025年12月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,600
试验地点
1
主要终点
Proportion of study participants with mRS scores of 0 - 1

研究概览

简要总结

A multicenter, retrospective, observational cohort study on intravenous thrombolysis beyond the time window for acute ischemic stroke

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with acute ischemic stroke, regardless of gender;
  • Age ≥ 18 years old;
  • Time from onset to treatment within 4.5 - 24 hours (the onset time refers to the last time when they appeared normal);
  • Complete relevant clinical data (including gender, age, mRS, NIHSS, etc.).

排除标准

  • 未提供

研究组 & 干预措施

Alteplase group

The research participants received Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours

Tenecteplase group

The research participants received Tenecteplase for Acute Ischemic Stroke at 4.5 to 24 Hours

结局指标

主要结局

Proportion of study participants with mRS scores of 0 - 1

时间窗: at 90 (±7) days

Proportion of study participants with mRS scores of 0 - 1

次要结局

  • Distribution of mRS scores ranging from 0 to 6(at 90 (±7) days)
  • Proportion of study participants with mRS scores of 0 - 2(at 90 (±7) days)
  • The proportion of study participants with a NIHSS score of ≤1 or a decrease of ≥8 points compared to the baseline(at 24 (±12) hours)
  • mortality rate(at 90 (±7) days)
  • Symptomatic intracranial hemorrhage(within 36 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验